PTC Therapeutics
PTCT
#2687
Rank
ยฃ4.65 B
Marketcap
ยฃ57.99
Share price
-0.76%
Change (1 day)
52.88%
Change (1 year)

Earnings for PTC Therapeutics (PTCT)

Earnings in 2025 (TTM): ยฃ0.57 Billion

According to PTC Therapeutics 's latest financial reports the company's current earnings are ยฃ1.77 Billion. In 2024 the company made an earning of -ยฃ0.28 Billion, an increase over its 2023 earnings that were of -ยฃ0.53 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for PTC Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ0.57 B-311.05%
2024 -ยฃ0.28 Billion-47.84%
2023 -ยฃ0.53 Billion18.49%
2022 -ยฃ0.45 Billion13.34%
2021 -ยฃ0.39 Billion28.64%
2020 -ยฃ0.31 Billion67.94%
2019 -ยฃ0.19 Billion87.28%
2018 -ยฃ96.17 Million64.95%
2017 -ยฃ58.3 Million-45.13%
2016 -ยฃ0.11 Billion-16.72%
2015 -ยฃ0.13 Billion72.64%
2014 -ยฃ73.9 Million90.89%
2013 -ยฃ38.72 Million96.58%
2012 -ยฃ19.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vertex Pharmaceuticals
VRTX
ยฃ3.34 B 502.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-ยฃ0.19 Billion-134.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-ยฃ0.13 Billion-121.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
-ยฃ0.42 Billion-174.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-ยฃ0.11 Billion-118.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ12.32 B 2,115.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland